A randomized phase II trial of first-line combination chemotherapy with nintedanib / placebo for patients with advanced or recurrent endometrial cancer.
BGOG-en-1
Belgium and Luxembourg Gynaecological Oncology Group
Contact info
About Us
About us and the European Network of Gynaecological Oncological Trial Groups. Learn more ->
Supports
The BGOG supports Mole-Chorio Belgium. Learn more ->